实用肿瘤杂志

参考文献

[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.

[2] Xia CF, Dong XS, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J, 2022, 135(5): 584-590.

[3] Lococo F, Cusumano G, de Filippis AF, et al. Current practices in the management of pulmonary ground-glass opacities: a survey of SICT members[J]. Ann Thorac Surg, 2018, 106(5): 1504-1511.

[4] Ye X, Fan WJ, Wang H, et al. Expert consensus workshop report: guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition)[J]. J Cancer Res Ther, 2018, 14(4): 730-744.

[5] Ettinger DS, Wood DE, Aisner DL, et al. NCCN guidelines insights: non-small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines[J]. J Natl Compr Canc Netw, 2023, 21(4): 340-350.

[6] Abbas G. Microwave ablation[J]. Semin Thorac Cardiovasc Surg, 2011, 23(1): 81-83.

[7] Ye X, Fan WJ, Wang ZM, et al. Expert consensus on thermal ablation therapy of pulmonary subsolid nodules (2021 edition)[J]. J Cancer Res Ther, 2021, 17(5): 1141-1156.

[8] Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J]. Cancer, 1994, 74(3): 817-825.

[9] 董宝玮, 梁萍, 于小玲, 等. 超声引导下微波治疗肝癌的实验研究及临床初步应用[J]. 中华医学杂志, 1996, 76(2): 8-12.

[10] 叶欣, 王忠敏. 肺部肿瘤消融治疗[M]. 北京: 人民卫生出版社, 2019: 69-73.

[11] Huang HM, Zhang LF, Moser MAJ, et al. A review of antenna designs for percutaneous microwave ablation[J]. Phys Med, 2021, 84: 254-264.

[12] Kim H, Kim D. Numerical study of the induction of intratumoral apoptosis under microwave ablation by changing slot length of microwave coaxial antenna[J]. Med Biol Eng Comput, 2024, 62(3): 1-11.

[13] Zeinali N, Sebek J, Fallahi H, et al. Transmission coefficient-based monitoring of microwave ablation: development and experimental evaluation in ex vivo tissue[J]. IEEE Trans Biomed Eng, 2024, 71(4): 1269-1280.

[14] Tabuse Y, Tabuse K, Mori K, et al. Percutaneous microwave tissue coagulation in liver biopsy: experimental and clinical studies[J]. Nihon Geka Hokan, 1986, 55(3): 381-392.

[15] 冯威健, 刘巍, 李彩英, 等. 经皮微波凝固疗法治疗肺癌的临床应用[J]. 中华肿瘤杂志, 2002, 24(4): 80-82.

[16] Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria: a 10-year update[J]. Radiology, 2014, 273(1): 241-260.

[17] Venturini M, Cariati M, Marra P, et al. CIRSE standards of practice on thermal ablation of primary and secondary lung tumours[J]. Cardiovasc Intervent Radiol, 2020, 43(5): 667-683.

[18] 叶欣, 范卫君. 影像引导下热消融治疗原发性和转移性肺部肿瘤临床实践指南(2021年版)[J]. 中华内科杂志, 2021, 60(12): 1088-1105.

[19] Wood DE, Kazerooni EA, Baum SL, et al. Lung cancer screening, version 4.2021, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2021,19(5): 95-97.

[20] Ye X, Fan WJ, Wang ZM, et al. Clinical practice guidelines on image-guided thermal ablation of primary and metastatic lung tumors (2022 edition)[J]. J Cancer Res Ther, 2022, 18(5): 1213-1230.

[21] Lu AM, Woodrum DA, Felmlee JP, et al. Improved MR-thermometry during hepatic microwave ablation by correcting for intermittent electromagnetic interference artifacts[J]. Phys Med, 2020, 71: 100-107.

[22] Iguchi T, Hiraki T, Matsui Y, et al. In vivo microwave ablation of normal swine lung at high-power, short-duration settings[J]. Acta Med Okayama, 2022, 76(1): 57-62.

[23] Wei ZG, Yang X, Wu J, et al. SPACES: our team's experience in lung tumor microwave ablation[J]. J Cancer Res Ther, 2023, 19(1): 1-13.

[24] 范卫杰, 张冬. 影像组学及深度学习在肺结节良恶性鉴别诊断中的新理念[J]. 中华肺部疾病杂志:电子版, 2021, 14(5): 549-553.

[25] Wang MX, Wei ZG, Ye X. Issues and prospects of image-guided thermal ablation in the treatment of primary and metastatic lung tumors[J]. Thorac Cancer, 2023, 14(1): 110-115.

[26] 张旭辉, 彭玉兰, 廖中凡, 等. 热消融治疗肿瘤的研究进展[J]. 临床超声医学杂志, 2022, 24(10): 772-775.

[27] Yang X, Ye X, Zheng AM, et al. Percutaneous microwave ablation of stage Ⅰ medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases[J]. J Surg Oncol, 2014, 110(6): 758-763.

[28] Uhlig J, Ludwig JM, Goldberg SB, et al. Survival rates after thermal ablation versus stereotactic radiation therapy for stage 1 non-small cell lung cancer: a national cancer database study[J]. Radiology, 2018, 289(3): 862-870.

[29] Han XY, Yang X, Huang GH, et al. Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: a multicenter retrospective study[J]. Thorac Cancer, 2019, 10(12): 2236-2242.

[30] Zhao H, Steinke K. Long-term outcome following microwave ablation of early-stage non-small cell lung cancer[J]. J Med Imaging Radiat Oncol, 2020, 64(6): 787-793.

[31] Nance M, Khazi Z, Kaifi J, et al. Computerized tomography-guided microwave ablation of patients with stage Ⅰ non-small cell lung cancers: a single-institution retrospective study[J]. J Clin Imaging Sci, 2021, 11: 7.

[32] Ni Y, Huang GH, Yang X, et al. Microwave ablation treatment for medically inoperable stage Ⅰ non-small cell lung cancers: long-term results[J]. Eur Radiol, 2022, 32(8): 5616-5622.

[33] Wang J, Li B, Zhang L, et al. Safety and local efficacy of computed tomography-guided microwave ablation for treating early-stage non-small cell lung cancer adjacent to bronchovascular bundles[J]. Eur Radiol, 2024, 34(1): 236-246.

[34] Yao W, Lu MJ, Fan WZ, et al. Comparison between microwave ablation and lobectomy for stage Ⅰ non-small cell lung cancer: a propensity score analysis[J]. Int J Hyperthermia, 2018, 34(8): 1329-1336.

[35] Chan MV, Huo YR, Cao C, et al. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage Ⅰ non-small cell lung cancer (NSCLC): a systematic review and meta-analysis[J]. Eur Radiol, 2021, 31(7): 5421-5433.

[36] 訾洋, 韦伟, 杨泽军, 等. 外科切除与微波消融对非小细胞肺癌治疗的应用比较[J]. 中华介入放射学电子杂志, 2021, 9(3): 331-335, 344.

[37] Ni Y, Peng JC, Yang X, et al. Multicentre study of microwave ablation for pulmonary oligorecurrence after radical resection of non-small-cell lung cancer[J]. Br J Cancer, 2021, 125(5): 672-678.

[38] Laeseke P, Ng C, Ferko N, et al. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: a systematic literature review and meta-analysis[J]. Lung Cancer, 2023, 182: 107259.

[39] Succony L, Rassl DM, Barker AP, et al. Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies[J]. Cancer Treat Rev, 2021, 99: 102237.

[40] Liang XY, Zhang C, Ye X. Overdiagnosis and overtreatment of ground-glass nodule-like lung cancer[J]. Asia Pac J Clin Oncol, 2024, Epub ahead of print.

[41] Lin SC, Yang CL, Guo XT, et al. Simultaneous uniportal video-assisted thoracic surgery of bilateral pulmonary nodules[J]. J Cardiothorac Surg, 2021, 16(1): 42.

[42] Tian H, Bai GY, Yang ZL, et al. Multiple primary lung cancer: Updates of clinical management and genomic features[J]. Front Oncol, 2023, 13: 1034752.

[43] Murphy MC, Wrobel MM, Fisher DA, et al. Update on image-guided thermal lung ablation: society guidelines, therapeutic alternatives, and postablation imaging findings[J]. Am J Roentgenol, 2022, 219(3): 471-485.

[44] Yang X, Ye X, Lin ZY, et al. Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity-lung adenocarcinoma: a pilot study[J]. J Cancer Res Ther, 2018, 14(4): 764-771.

[45] Huang GH, Yang X, Li WH, et al. A feasibility and safety study of computed tomography-guided percutaneous microwave ablation: a novel therapy for multiple synchronous ground-glass opacities of the lung[J]. Int J Hyperthermia, 2020, 37(1): 414-422.

[46] Han XY, Wei ZG, Zhao ZX, et al. Cost and effectiveness of microwave ablation versus video-assisted thoracoscopic surgical resection for ground-glass nodule lung adenocarcinoma[J]. Front Oncol, 2022, 12: 962630.

[47] Zarogoulidis P, Hohenforst-Schmidt W, Chen W, et al. Endobronchial radiofrequency ablation for pulmonary nodules with radial-ebus and navigation: pros and cons[J]. J Cancer, 2023, 14(9): 1562-1570.

[48] Zhou DT, Yao TY, Huang XJ, et al. Real-world comprehensive diagnosis and "Surgery + X" treatment strategy of early-stage synchronous multiple primary lung cancer[J]. Cancer Med, 2023, 12(12): 12996-13006.

[49] Chan JWY, Siu ICH, Chang ATC, et al. Transbronchial techniques for lung cancer treatment: where are we now?[J]. Cancers, 2023, 15(4): 1068.

[50] Wei ZG, Ye X, Yang X, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer[J]. Cardiovasc Intervent Radiol, 2015, 38(1): 135-142.

[51] Ni X, Han JQ, Ye X, et al. Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC[J]. Onco Targets Ther, 2015, 8: 3227-3235.

[52] Wei ZG, Yang X, Ye X, et al. Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase Ⅲ clinical trial[J]. Eur Radiol, 2020, 30(5): 2692-2702.

[53] Huang GH, Li WH, Meng M, et al. Synchronous microwave ablation combined with cisplatin intratumoral chemotherapy for large non-small cell lung cancer[J]. Front Oncol, 2022, 12: 955545.

[54] 林岩, 廖艺芳, 雍雅智. CT引导下经皮穿刺微波消融在中晚期肺癌患者中的应用效果研究[J]. 中外医疗, 2022, 41(35): 31-35.

[55] Xu RD, Chen JJ, Chen DH, et al. CT-guided percutaneous microwave ablation combined with local radiotherapy or chemotherapy of malignant pulmonary tumors[J]. Curr Radiopharm, 2024, Epub ahead of print.

[56] Ni Y, Liu BD, Ye X, et al. Local thermal ablation with continuous EGFR tyrosine kinase inhibitors for EGFR-mutant non-small cell lung cancers that developed extra-central nervous system (CNS) oligoprogressive disease[J]. Cardiovasc Intervent Radiol, 2019, 42(5): 693-699.

[57] Ni Y, Ye X, Yang X, et al. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment[J]. J Cancer Res Clin Oncol, 2020, 146(1): 197-203.

[58] Huang YH, Kong YM, Wei ZG, et al. Image-guided thermal ablation for patients with epidermal growth factor receptor-mutant nonsmall cell lung cancer[J]. Asia Pac J Clin Oncol, 2023, 19(4): 427-433.

[59] 周娟, 苏春霞. 2023年ASCO非小细胞肺癌靶向和免疫治疗进展[J]. 实用肿瘤杂志, 2023, 38(4): 305-311.

[60] Wei ZG, Yang X, Ye X, et al. Camrelizumab combined with microwave ablation improves the objective response rate in advanced non-small cell lung cancer[J]. J Cancer Res Ther, 2019, 15(7): 1629-1634.

[61] Huang YH, Wang J, Hu YT, et al. Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer[J]. Front Oncol, 2022, 12:938827.

[62] 刘涛, 郭晨凡, 吴鲧. 多次微波消融治疗复发转移性肺癌1例并文献复习[J]. 中国临床研究, 2023, 36(10): 1577-1579.

[63] 姚源山, 华青旺, 高文. 晚期非小细胞肺癌患者免疫治疗的预后相关因素分析[J]. 实用肿瘤杂志, 2023, 38(3): 239-245.

[64] 罗盛男, 陶冀. 微波消融术联合免疫治疗在肿瘤治疗中的应用及进展[J]. 现代肿瘤医学, 2022, 30(1): 159-162.

[65] Zhang XS, Ye X, Zhang KX, et al. Computed tomography-guided microwave ablation combined with osteoplasty for the treatment of bone metastases: a multicenter clinical study[J]. J Vasc Interv Radiol, 2021, 32(6): 861-868.

[66] Hu XH, Hu QK, He Y, et al. Efficacy and safety of microwave ablation and its synergistic potential in the treatment of early-stage non-small cell lung cancer[J]. Clin Imaging, 2024, 107: 110070.